BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30015257)

  • 1. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
    Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
    Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
    Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
    JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
    Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K
    Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
    Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
    Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
    De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.
    Karasawa K; Kunogi H; Hirai T; Hojo H; Hirowatari H; Izawa H; Ito K; Sasai K; Kawashima M; Furuya T; Sugimoto S; Kurokawa C; Ozawa S; Saito M
    Breast Cancer; 2014 Jul; 21(4):402-8. PubMed ID: 22968629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study.
    Meattini I; Poortmans P; Kirova Y; Saieva C; Visani L; Salvestrini V; Kim J; Jung W; Olmetto E; Mariotti M; Desideri I; Fourquet A; Livi L; Kim K
    Acta Oncol; 2020 Feb; 59(2):188-195. PubMed ID: 31760849
    [No Abstract]   [Full Text] [Related]  

  • 9. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
    Smith BD; Bentzen SM; Correa CR; Hahn CA; Hardenbergh PH; Ibbott GS; McCormick B; McQueen JR; Pierce LJ; Powell SN; Recht A; Taghian AG; Vicini FA; White JR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):59-68. PubMed ID: 20638191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.
    Chan EK; Tabarsi N; Tyldesley S; Khan M; Woods R; Speers C; Weir L
    Am J Clin Oncol; 2016 Oct; 39(5):473-8. PubMed ID: 24824143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes.
    Chan EK; Woods R; McBride ML; Virani S; Nichol A; Speers C; Wai ES; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):786-92. PubMed ID: 24606848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis.
    Rice SR; Feigenberg SJ; Hamza M; Molitoris JK; Bentzen SM; Tkaczuk KHR; Rosenblatt PM; Bellavance EC; Nichols EM
    Breast Cancer Res Treat; 2019 Jun; 175(2):473-478. PubMed ID: 30796656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer.
    Lee SW; Kim YJ; Shin KH; Kim K; Chie EK; Han W; Im SA; Jung SY; Lee KS; Lee ES
    Medicine (Baltimore); 2016 May; 95(19):e3320. PubMed ID: 27175630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
    Olivotto IA; Link E; Phillips C; Whelan TJ; Bryant G; Kunkler IH; Westenberg AH; Purohit K; Ahern V; Graham PH; Akra M; McArdle O; Ludbrook JJ; Harvey JA; Maduro JH; Kirkove C; Gruber G; Martin JD; Campbell ID; Delaney GP; Chua BH;
    Radiother Oncol; 2020 Jan; 142():180-185. PubMed ID: 31431385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Pathways: A Catalyst for the Adoption of Hypofractionation for Early-Stage Breast Cancer.
    Chapman BV; Rajagopalan MS; Heron DE; Flickinger JC; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):854-61. PubMed ID: 26530754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.
    Shaitelman SF; Lei X; Thompson A; Schlembach P; Bloom ES; Arzu IY; Buchholz D; Chronowski G; Dvorak T; Grade E; Hoffman K; Perkins G; Reed VK; Shah SJ; Stauder MC; Strom EA; Tereffe W; Woodward WA; Amaya DN; Shen Y; Hortobagyi GN; Hunt KK; Buchholz TA; Smith BD
    J Clin Oncol; 2018 Oct; 36(35):JCO1800317. PubMed ID: 30379626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
    Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
    Polgár C; Fodor J; Major T; Sulyok Z; Kásler M
    Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the use of hypofractionated and conventionally fractionated radiotherapy in early breast cancer: A single-center real-world study in Taiwan.
    Chuang WK; Cheng SH; Hung CF; Huang TT; Jen CW; Yen JH; Tsai YC
    J Formos Med Assoc; 2022 Aug; 121(8):1588-1595. PubMed ID: 35094914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.